Invesco S&P 500 Equal Weight Health Care ETF (RYH)

Key Metrics

TER 0.40% per year

Distribution policy Distributing

Fund size USD 689 M

Inception date November 1, 2006

Holdings 62

Fund currency USD

Fund domicile US

Provider Invesco

For full official fund details, factsheets, and holdings, visit invesco.com (opens in new tab).

Historical Return

Last updated: Jul 15, 2026

1 Year N/A

3 Years (avg.) +0.0% +0.1% Div

5 Years (avg.) -0.6% +0.1% Div

Risk & Analysis Metrics

Last updated: Jul 15, 2026

Volatility

N/A 1 Year

0.00% 3 Years

12.59% 5 Years

17.15% 10 Years

Max Drawdown

N/A 1 Year

0.00% 3 Years

-22.34% 5 Years

-30.57% 10 Years

Sharpe Ratio

N/A 1 Year

N/A 3 Years

-0.34 5 Years

0.22 10 Years

Return Triangle (Heatmap)

Last updated: Jul 15, 2026

	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
2014	-3.9%	-18.4%	-22.7%	-24.8%	-20.5%	-14.1%	-10.2%	-6.6%	-6.9%	-6.2%	-5.7%	-5.2%
2015		-30.7%	-30.7%	-30.7%	-24.2%	-16.1%	-11.2%	-6.9%	-7.2%	-6.5%	-5.9%	-5.3%
2016			-30.7%	-30.7%	-21.9%	-11.9%	-6.6%	-2.2%	-3.3%	-2.9%	-2.6%	-2.3%
2017				-30.7%	-17.1%	-4.6%	0.6%	4.7%	2.3%	1.9%	1.6%	1.4%
2018					-0.8%	11.9%	13.9%	16.1%	10.5%	8.6%	7.3%	6.4%
2019						26.1%	22.0%	22.3%	13.5%	10.6%	8.8%	7.5%
2020							17.9%	20.5%	9.6%	7.0%	5.6%	4.6%
2021								23.1%	5.7%	3.6%	2.7%	2.2%
2022									-9.2%	-4.9%	-3.3%	-2.5%
2023										-0.4%	-0.2%	-0.1%
2024											0.0%	0.0%
2025												0.0%

Distributions

*by ETF Portfolio Weight Last updated: Jul 15, 2026

Profit Margin Distribution

< 0%

10%

1y 3y N/A N/A

0 - 5%

18%

1y 3y N/A N/A

5 - 10%

21%

1y 3y N/A N/A

10 - 15%

16%

1y 3y N/A N/A

15 - 20%

15%

1y 3y N/A N/A

20 - 30%

16%

1y 3y N/A N/A

30 - 40%

1y 3y N/A N/A

> 40%

1y 3y N/A N/A

P/E Ratio Distribution

< 0

10%

1y 3y N/A N/A

0 - 10

1y 3y N/A N/A

10 - 15

1y 3y N/A N/A

15 - 20

16%

1y 3y N/A N/A

20 - 25

12%

1y 3y N/A N/A

25 - 35

25%

1y 3y N/A N/A

35 - 50

23%

1y 3y N/A N/A

> 50

1y 3y N/A N/A

Discounted Cash Flow

Weighted Average Undervaluation

N/A

Undervalued

> 60%

1y 3y N/A N/A

45 - 60%

1y 3y N/A N/A

30 - 45%

1y 3y N/A N/A

15 - 30%

1y 3y N/A N/A

Fair (±15%)

1y 3y N/A N/A

Overvalued

15 - 30%

1y 3y N/A N/A

30 - 45%

1y 3y N/A N/A

45 - 60%

1y 3y N/A N/A

> 60%

1y 3y N/A N/A

Market Cap Size Distribution

Micro Cap

0.0%

1y 3y N/A N/A

Small Cap

0.0%

1y 3y N/A N/A

Mid Cap

3.4%

1y 3y N/A N/A

Large Cap

87.5%

1y 3y N/A N/A

Mega Cap

9.1%

1y 3y N/A N/A

Micro: < $300M Small: $300M–$2B Mid: $2B–$10B Large: $10B–$200B Mega: > $200B

Average metrics of all companies in portfolio

Last updated: Jul 19, 2026

Market
Average

Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares.	$107B	-
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price.	0.96%	2.03%
Beta Indicates the relationship between the price performance of a share and the market.	0.78	-
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth.	32.35	28.84
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything	-28.51	-
Profitable Companies	90%	-
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued.	42.42	18.09
Price to Sales Ratio Market cap divided by the revenue in the most recent year.	4.17	8.08
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company	5.5	10.33

Market
Average

Enterprise Value to EBIT Enterprise Value divided by EBIT	22.72	19.5
Enterprise Value to Revenue Enterprise value divided by revenue	4.43	8.09
Total Debt to Enterprise Value Total debt divided by enterprise value	0.18	0.04
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary.	-0.62	0.27
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability.	9.71%	20.92%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago.	-0.2%	-113.9%
Return on Equity Equity divided by market cap.	14.32%	2.94%
Return on Assets Indicates a company's profitability in relation to its total assets.	6.65%	4.11%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits.	12.67%	3.71%

Sectors

Manufacturing	56.4%
Finance and Insurance	11.2%
Health Care and Social Assistance	11.1%
Professional, Scientific, and Technical Services	7.0%
Wholesale Trade	6.4%
Retail Trade	2.0%
Healthcare	1.5%
Other	4.4%

Countries

United States	96.6%
Other	1.7%
Ireland	1.6%

Limit holdings to companies in a single sector.

$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%

Market Cap

P/E Ratio

Total Investment

Weight

Centene Corp.

CNC - Finance and Insurance

Market Cap $32.81B

P/E Ratio -5.1

Dividends 0.0%

Total Investment $18.35M

Weight 2.66%

Loading details…

Humana Inc.

HUM - Health Care and Social Assistance

Market Cap $48.02B

P/E Ratio 42.6

Dividends 0.9%

Total Investment $16.95M

Weight 2.46%

Loading details…

Unitedhealth Group Inc

UNH - Finance and Insurance

Market Cap $386.95B

P/E Ratio 32.1

Dividends 2.1%

Total Investment $15.92M

Weight 2.31%

Loading details…

Anthem Inc

ANTM - Finance and Insurance

Market Cap $114.59B

P/E Ratio 16.6

Dividends 1.8%

Total Investment $15.91M

Weight 2.31%

Loading details…

West Pharmaceutical Services, Inc.

WST - Health Care and Social Assistance

Market Cap $25.33B

P/E Ratio 47.7

Dividends 0.2%

Total Investment $15.3M

Weight 2.22%

Loading details…

Cigna Group (The)

CI - Finance and Insurance

Market Cap $74.45B

P/E Ratio 11.9

Dividends 2.2%

Total Investment $13.65M

Weight 1.98%

Loading details…

CVS Health Corp

CVS - Retail Trade

Market Cap $137.12B

P/E Ratio 46.5

Dividends 2.5%

Total Investment $13.48M

Weight 1.96%

Loading details…

Viatris Inc

VTRS - Finance and Insurance

Market Cap $20.14B

P/E Ratio -65.5

Dividends 2.8%

Total Investment $13.11M

Weight 1.90%

Loading details…

Mettler-Toledo International, Inc.

MTD - Manufacturing

Market Cap $26.47B

P/E Ratio 30.7

Dividends 0.0%

Total Investment $12.75M

Weight 1.85%

Loading details…

Waters Corp.

WAT - Manufacturing

Market Cap $24.05B

P/E Ratio 46.8

Dividends 0.0%

Total Investment $12.74M

Weight 1.85%

Loading details…

Bio-Techne Corp

TECH - Manufacturing

Market Cap $11.29B

P/E Ratio 101.6

Dividends 0.4%

Total Investment $12.65M

Weight 1.83%

Loading details…

Bristol-Myers Squibb Co.

BMY - Manufacturing

Market Cap $124.04B

P/E Ratio 17.1

Dividends 4.1%

Total Investment $12.38M

Weight 1.80%

Loading details…

Align Technology, Inc.

ALGN - Manufacturing

Market Cap $12.66B

P/E Ratio 29.6

Dividends 0.0%

Total Investment $12.34M

Weight 1.79%

Loading details…

Incyte Corp.

INCY - Professional, Scientific, and Technical Services

Market Cap $23.42B

P/E Ratio 16.1

Dividends 0.0%

Total Investment $12.33M

Weight 1.79%

Loading details…

DaVita Inc

DVA - Health Care and Social Assistance

Market Cap $15.21B

P/E Ratio 23.3

Dividends 0.0%

Total Investment $12.28M

Weight 1.78%

Loading details…

Agilent Technologies Inc.

A - Professional, Scientific, and Technical Services

Market Cap $37.13B

P/E Ratio 26.3

Dividends 0.8%

Total Investment $12.27M

Weight 1.78%

Loading details…

Solventum Corp

SOLV

Market Cap $14.08B

P/E Ratio 9.9

Dividends 0.0%

Total Investment $12.21M

Weight 1.77%

Loading details…

Biogen Inc

BIIB - Manufacturing

Market Cap $30.41B

P/E Ratio 22.0

Dividends 0.0%

Total Investment $12.18M

Weight 1.77%

Loading details…

Charles River Laboratories International Inc.

CRL - Professional, Scientific, and Technical Services

Market Cap $10.81B

P/E Ratio -59.8

Dividends 0.0%

Total Investment $12.11M

Weight 1.76%

Loading details…

Edwards Lifesciences Corp

EW - Manufacturing

Market Cap $49.36B

P/E Ratio 45.4

Dividends 0.0%

Total Investment $12.03M

Weight 1.74%

Loading details…

Key Metrics

Compare similar ETFs

Historical Return

Risk & Analysis Metrics

Volatility

Max Drawdown

Sharpe Ratio

Return Triangle (Heatmap)

Distributions

Profit Margin Distribution

P/E Ratio Distribution

Discounted Cash Flow

Market Cap Size Distribution

Portfolio Concentration

Latest News

UnitedHealth's AI Bet Paid Off. Now It Is Selling the Playbook

UnitedHealth Says AI Now Runs Every Function of Its Business

UnitedHealth Group Q2: The Real Test Begins Now (Downgrade)

Average metrics of all companies in portfolio

Sectors

Countries

Stock Screener

Centene Corp.

Centene Corp.

Humana Inc.

Humana Inc.

Unitedhealth Group Inc

Unitedhealth Group Inc

Anthem Inc

Anthem Inc

West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc.

Cigna Group (The)

Cigna Group (The)

CVS Health Corp

CVS Health Corp

Viatris Inc

Viatris Inc

Mettler-Toledo International, Inc.

Mettler-Toledo International, Inc.

Waters Corp.

Waters Corp.

Bio-Techne Corp

Bio-Techne Corp

Bristol-Myers Squibb Co.

Bristol-Myers Squibb Co.

Align Technology, Inc.

Align Technology, Inc.

Incyte Corp.

Incyte Corp.

DaVita Inc

DaVita Inc

Agilent Technologies Inc.

Agilent Technologies Inc.

Solventum Corp

Solventum Corp

Biogen Inc

Biogen Inc

Charles River Laboratories International Inc.

Charles River Laboratories International Inc.

Edwards Lifesciences Corp

Edwards Lifesciences Corp

Cookie Settings